Ceramide acts upstream of S1P by inhibiting Akt phosphorylation: it dephosphorylates Akt via PP2A, which impairs NO bioavailability, leading to reduced cell viability and endothelial dysfunction [19]. The gene discussed is PTPA; the disease is endothelial dysfunction.